Glaucoma implant study halted early – results pending
NCT ID NCT04770324
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 30 times
Summary
This study tested a new device called Supraflow, implanted in the eye to help drain fluid and lower pressure in people with open-angle glaucoma. It included 22 adults aged 50 and older whose glaucoma medications were not working well enough. The study was terminated early, so full results on safety and effectiveness are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA, OPEN ANGLE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Malayan Center
Yerevan, 0033, Armenia
Conditions
Explore the condition pages connected to this study.